Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.

Okato A, Arai T, Yamada Y, Sugawara S, Koshizuka K, Fujimura L, Kurozumi A, Kato M, Kojima S, Naya Y, Ichikawa T, Seki N.

Int J Mol Sci. 2017 Sep 13;18(9). pii: E1969. doi: 10.3390/ijms18091969.

2.

Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.

Arai T, Okato A, Kojima S, Idichi T, Koshizuka K, Kurozumi A, Kato M, Yamazaki K, Ishida Y, Naya Y, Ichikawa T, Seki N.

Cancer Sci. 2017 Jul 26. doi: 10.1111/cas.13331. [Epub ahead of print]

3.

Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.

Goto Y, Kurozumi A, Arai T, Nohata N, Kojima S, Okato A, Kato M, Yamazaki K, Ishida Y, Naya Y, Ichikawa T, Seki N.

Br J Cancer. 2017 Jul 25;117(3):409-420. doi: 10.1038/bjc.2017.191. Epub 2017 Jun 22.

PMID:
28641312
4.

Dual strands of pre-miR‑150 (miR‑150‑5p and miR‑150‑3p) act as antitumor miRNAs targeting SPOCK1 in naïve and castration-resistant prostate cancer.

Okato A, Arai T, Kojima S, Koshizuka K, Osako Y, Idichi T, Kurozumi A, Goto Y, Kato M, Naya Y, Ichikawa T, Seki N.

Int J Oncol. 2017 Jul;51(1):245-256. doi: 10.3892/ijo.2017.4008. Epub 2017 May 17.

PMID:
28534948
5.

Severe Hypophosphatemia Following Denosumab Administration in a Hemodialysis Patient with Progressive Prostate Cancer.

Masuda H, Kaga K, Inahara M, Araki K, Kojima S, Naya Y, Takano M.

Urol Case Rep. 2017 Apr 26;13:63-65. doi: 10.1016/j.eucr.2016.11.019. eCollection 2017 Jul.

6.

Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.

Kamiya N, Suzuki H, Suyama T, Kobayashi M, Fukasawa S, Sekita N, Mikami K, Nihei N, Naya Y, Ichikawa T.

Int J Clin Oncol. 2017 Apr;22(2):353-358. doi: 10.1007/s10147-016-1048-z. Epub 2016 Oct 15.

PMID:
27744487
7.

Usefulness of R.E.N.A.L Nephrometry Scoring System and Centrality Index Score for Predicting Outcome of Laparoscopic Partial Nephrectomy.

Sugiura M, Suyama T, Kanesaka M, Fujimoto A, Hou K, Araki K, Masuda H, Kojima S, Naya Y.

J Laparoendosc Adv Surg Tech A. 2016 Oct;26(10):784-788. Epub 2016 Jul 19.

PMID:
27732324
8.

The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma.

Goto Y, Kurozumi A, Nohata N, Kojima S, Matsushita R, Yoshino H, Yamazaki K, Ishida Y, Ichikawa T, Naya Y, Seki N.

Oncotarget. 2016 Sep 13;7(37):59070-59086. doi: 10.18632/oncotarget.10887.

9.

The roles of microRNAs in the progression of castration-resistant prostate cancer.

Kojima S, Goto Y, Naya Y.

J Hum Genet. 2017 Jan;62(1):25-31. doi: 10.1038/jhg.2016.69. Epub 2016 Jun 9. Review.

PMID:
27278789
10.

Physiological and Biochemical Responses to Continuous Saline Irrigation Inside the Abdominal Cavity in Anesthetized Pigs.

Ishii T, Igarashi T, Naya Y, Aoe T, Isono S.

J Laparoendosc Adv Surg Tech A. 2016 Aug;26(8):600-5. doi: 10.1089/lap.2015.0463. Epub 2016 May 19.

PMID:
27195464
11.

Small-Incision Laparoscopy-Assisted Surgery Under Abdominal Cavity Irrigation in a Porcine Model.

Igarashi T, Ishii T, Aoe T, Yu WW, Ebihara Y, Kawahira H, Isono S, Naya Y.

J Laparoendosc Adv Surg Tech A. 2016 Feb;26(2):122-8. doi: 10.1089/lap.2015.0461. Epub 2016 Jan 8.

12.

Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma.

Namekawa T, Utsumi T, Kawamura K, Kamiya N, Imamoto T, Takiguchi T, Hashimoto N, Tanaka T, Naya Y, Suzuki H, Ichikawa T.

Surgery. 2016 Mar;159(3):763-70. doi: 10.1016/j.surg.2015.09.016. Epub 2015 Oct 21.

PMID:
26477475
13.

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.

Goto Y, Kojima S, Nishikawa R, Kurozumi A, Kato M, Enokida H, Matsushita R, Yamazaki K, Ishida Y, Nakagawa M, Naya Y, Ichikawa T, Seki N.

Br J Cancer. 2015 Sep 29;113(7):1055-65. doi: 10.1038/bjc.2015.300. Epub 2015 Sep 1.

14.

Risk of New-Onset Dyslipidemia After Laparoscopic Adrenalectomy in Patients with Primary Aldosteronism.

Kaga M, Utsumi T, Tanaka T, Kono T, Nagano H, Kawamura K, Kamiya N, Imamoto T, Nihei N, Naya Y, Suzuki H, Ichikawa T.

World J Surg. 2015 Dec;39(12):2935-40. doi: 10.1007/s00268-015-3197-z.

PMID:
26296835
15.

MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.

Nishikawa R, Goto Y, Kurozumi A, Matsushita R, Enokida H, Kojima S, Naya Y, Nakagawa M, Ichikawa T, Seki N.

Int J Urol. 2015 Sep;22(9):867-77. doi: 10.1111/iju.12829. Epub 2015 Jun 7.

16.
17.

Therapeutic designing for urethral obstruction by virtual urethra and flow dynamics simulation.

Ishii T, Nakamura K, Naya Y, Igarashi T.

Minim Invasive Ther Allied Technol. 2015 Jun;24(3):141-7. doi: 10.3109/13645706.2014.964260. Epub 2014 Oct 2.

PMID:
25273605
18.

The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer.

Goto Y, Kojima S, Nishikawa R, Enokida H, Chiyomaru T, Kinoshita T, Nakagawa M, Naya Y, Ichikawa T, Seki N.

Oncotarget. 2014 Sep 15;5(17):7748-59.

19.

Development of a novel nomogram to predict hypertension cure after laparoscopic adrenalectomy in patients with primary aldosteronism.

Utsumi T, Kamiya N, Endo T, Yano M, Kamijima S, Kawamura K, Imamoto T, Naya Y, Ichikawa T, Suzuki H.

World J Surg. 2014 Oct;38(10):2640-4. doi: 10.1007/s00268-014-2612-1.

PMID:
24831672
20.

Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer.

Nishikawa R, Goto Y, Kojima S, Enokida H, Chiyomaru T, Kinoshita T, Sakamoto S, Fuse M, Nakagawa M, Naya Y, Ichikawa T, Seki N.

Int J Oncol. 2014 Jul;45(1):401-10. doi: 10.3892/ijo.2014.2437. Epub 2014 May 9.

PMID:
24820027

Supplemental Content

Loading ...
Support Center